Position in SCYX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,211,955
New position
Shares Held
543,478
first reported quarter
Ownership
5.46%
of shares outstanding
% of Portfolio
1.16%
of 13F equity value
Holder Rank
#3
of 39 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Propel Bio Management, LLC holds $8,212,326 across 2 Drug Manufacturers - Specialty & Generic names. SCYX ranks #2 (26.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AQST |
Aquestive Therapeutics, Inc.
|
1,442,397 | $6,000,371 | |
| 2 | SCYX |
Scynexis Inc
This page
|
543,478 | $2,211,955 |
All Filings in SCYX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,211,955 | 543,478 | Shares | Defined | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||